Influenza-associated morbidity in children with cancer

Pediatric Blood and Cancer

Volumn 50, Issue 5, 2008, Pages 983-987

  Tasian, Sarah K ^a,b   Park, Julie R ^a   Martin, Emily T ^a   Englund, Janet A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Influenza; Pediatric; Respiratory virus

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; OSELTAMIVIR; RIBAVIRIN; RIMANTADINE;

ADOLESCENT; ADULT; ARTICLE; ASSISTED VENTILATION; BACTEREMIA; BACTERIAL INFECTION; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HUMAN; INFANT; INFLUENZA; LENGTH OF STAY; LYMPHOCYTOPENIA; MALE; MORBIDITY; MYCOSIS; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SOLID TUMOR; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BACTEREMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMORBIDITY; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 41849114590     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21472     Document Type: Article

References (27)

1. Park JR, Coughlin J, Hawkins D, et al. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. Med Ped Onc 2003;40:93-98.
2. Park JR, Fogarty S, Brogan TV. Clinical utility of bronchoalveolar lavage in pediatric cancer patients. Med Ped Onc 2002;39:175-180.
3. Kempe A, Hall CB, MacDonald NE, et al. Influenza in children with cancer. J Pediatr 1989;115:33-39.
4. Christensen MS, Nielsen LP, Hasle H. Few but severe viral infections in children with cancer: A prospective RT-PCR and PCR-based 12-month study. Pediatr Blood Cancer 2005,45:945-951.
5. Maltezou HC, Kafetzis DA, Abisaid D, et al. Viral infections in children undergoing hematopoeitic stem cell transplant. Pediatr Infect Dis J 2000;19:307-312.
6. Luján-Zilbermann J, Benaim E, Tong X, et al. Respiratory virus infections in pediatric hematopoeitic stem cell transplantation. Clin Infect Dis 2001;33:962-968.
7. Apalsch A, Green M, Ledesma-Medina J, et al. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995;20:394-399.
8. Pohl C, Green M, Wald ER, et al. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992; 165:166-169.
9. Madhi SA, Ramasamy N, Bessellar TG, et al. Lower respiratory tract infections associated with influenza A and B viruses in an area with high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J 2002;21:291-297.
10. Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer. Cancer 1977;39:350-353.
11. Arola M, Ruuskanen O, Ziegler T, et al. Respiratory virus infections during anti-cancer treatment in children. Pediatr Infect Dis J 1995;14:690-694.
12. Mendoza Sánchez M, Ruiz-Contreras J, Vicanco JL, et al. Respiratory virus infections in children with cancer or HIV infection. J Pediatr Hematol Oncol 2006;28:154-159.
13. Kuypers J, Wright N, Ferrenberg J, et al. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 2006;44: 382-2388.
14. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997;102:10-18.
15. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778-782.
16. Yousuf HM, Englund J, Couch R, et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis 1997;24: 1095-1099.
17. Nichols WG, Guthrie KA, Corey L, et al. Influenza infections after hematopoeitic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004;39:1300-1306.
18. Kiso M, Mitamura K, Sakai-Tagawa YS, et al. Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet 2004;364:759-765.
19. Gubareva LV, Matrosovich MN, Brenner MK, et al. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Inf Dis 1998;178:1257-1262.
20. Ison MG, Gubareva LV, Atmar RL, et al. Recovery of drug-resistant influenza virus from immunocompromised patients: A case series. J Inf Dis 2006;193:760-764.
21. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Inf Dis 1998;26: 1418-1424.
22. American Academy of Pediatrics. Influenza. In: Pickering LK, editor. Red Book: Report of the Committee on Infectious Disease, 27th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 401-411.
23. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2006; 55:1-41.
24. Porter CC, Poehling KA, Hamilton R, et al. Influenza immunization practices among pediatric oncologists. J Pediatr Hematol Oncol 2003;25:134-138.
25. Chisholm J, Howe K, Taj M, et al. Influenza immunisation in children with solid tumours. Eur J Cancer 2005;41:2280-2287.
26. Chisholm JC, Devine T, Charlett A, et al. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001; 84:496-500.
27. Tsiodras S, Mooney JD, Hatzakis A. Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ 2007;334:293-294.